Dexilant and Yuflyma drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Dexilant (dexlansoprazole) and Yuflyma (adalimumab-aaty). Common drug interactions include arthralgia among females.
The phase IV clinical study analyzes what interactions people have when they take Dexilant and Yuflyma. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Dexilant?
Dexilant has active ingredients of dexlansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 57,103 Dexilant users. Check the latest studies of Dexilant.
What is Yuflyma?
Yuflyma has active ingredients of adalimumab-aaty. eHealthMe is studying from 341 Yuflyma users. Check the latest studies of Yuflyma.
11 people who take Dexilant and Yuflyma together, and have interactions are studied.
What are the common drug interactions of Dexilant and Yuflyma, by gender? *:
female:
- Arthralgia (joint pain)
- Peripheral swelling
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
- Hypersensitivity
male:
n/a
What are the common drug interactions of Dexilant and Yuflyma, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Arthralgia (joint pain)
- Peripheral swelling
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
- Hypersensitivity
60+:
n/a
What are the existing conditions these people have? *
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 8 people, 72.73%
- Pain: 4 people, 36.36%
- Indigestion: 4 people, 36.36%
- Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 9.09%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 9.09%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Dexilant and Yuflyma?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Dexilant and Yuflyma:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Dexilant:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Yuflyma:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dexilant and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Yuflyma and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on dexlansoprazole and adalimumab-aaty (the active ingredients of Dexilant and Yuflyma, respectively), and Dexilant and Yuflyma (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Emend vs. Promethegan, side effect and effectiveness comparison - 8 seconds ago
- Heather vs. Alesse, side effect and effectiveness comparison - 10 seconds ago
- Drug interactions of Linzess and Celexa - 12 seconds ago
- Benadryl vs. Pataday, side effect and effectiveness comparison - 28 seconds ago
- Could Ketorolac Tromethamine cause Stress And Anxiety? - 44 seconds ago
- Could Fenofibrate cause Quality Of Life Decreased? - 51 seconds ago
- Could Adbry cause Joint Pain? - 54 seconds ago
- Atenolol vs. Nadolol And Bendroflumethiazide, side effect and effectiveness comparison - 55 seconds ago
- Amerge vs. Magnesium Oxide, side effect and effectiveness comparison - a minute ago
- Could Valsartan cause Panic Reaction? - a minute ago